News genOway

Stocks

ALGEN

FR0004053510

Biotechnology & Medical Research

Real-time Euronext Paris 05:11:12 2026-10-29 EDT			5-day change	1st Jan Change
2.140 ^EUR	+1.90%		-2.73%	-21.03%

10-01	Taconic Biosciences, Inc. And genOway Partner To Expand U.S. Access To Advanced Humanized Mouse Models	CI
09-23	GenOway teams up with Taconic Biosciences to accelerate in the United States

All News

Mentions Relevance

10-01	Taconic Biosciences, Inc. And genOway Partner To Expand U.S. Access To Advanced Humanized Mouse Models	CI
09-23	GenOway teams up with Taconic Biosciences to accelerate in the United States
09-23	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2026	CI
03-30	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-16	GenOway : 20250627 Avis de convocation	PU
12-30	GenOway Société anonyme completed the acquisition of Data Science and AI assets in OMICS platform.	CI
12-15	GenOway Société anonyme agreed to acquire Data Science and AI assets in OMICS platform for ?7 million.	CI
11-19	GenOway Soars 18% on Strong Momentum from Chinese Joint Venture
11-18	Accélération du développement en Chine : la coentreprise genOway Shanghai devient un moteur clé de croissance pour le Groupe	PU
25-09-24	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-09-22	GenOway : Solides résultats semestriels 2025 avec une marge d’EBITDA à 16,9%	PU
25-03-27	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-09-23	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-07-19	GenOway: 15% growth in first-half sales
24-03-27	GenOway : Résultats annuels 2023	PU
23-11-22	GenOway: sharp rise, broker initiates buy recommendation
23-11-22	GenOway: Euroland initiates buy coverage
23-10-17	GenOway: creation of a joint venture in Shanghai
23-09-22	GenOway : Résultats du 1er semestre 2023	PU
23-09-22	GenOway: profitability target achieved ahead of schedule
23-09-20	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI
22-09-19	GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	CI
22-09-08	Sigma-Aldrich and genOway Expand Their CRISPR/CAS9 Strategic Alliance	CI
22-05-23	GenOway: Proposal of a new administrator	PU
22-04-28	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2021	CI